Yeo A - Search Results

1

The complex role of tumor-infiltrating macrophages.

Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. Christofides A, et al. Among authors: yeo a. Nat Immunol. 2022 Aug;23(8):1148-1156. doi: 10.1038/s41590-022-01267-2. Epub 2022 Jul 25. Nat Immunol. 2022. PMID: 35879449 Free PMC article. Review.

2

Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma.

Yeo AT, Charest A. Yeo AT, et al. J Cell Biochem. 2017 Sep;118(9):2516-2527. doi: 10.1002/jcb.25948. Epub 2017 May 3. J Cell Biochem. 2017. PMID: 28230277 Free PMC article. Review.

3

Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.

Yeo AT, Rawal S, Delcuze B, Christofides A, Atayde A, Strauss L, Balaj L, Rogers VA, Uhlmann EJ, Varma H, Carter BS, Boussiotis VA, Charest A. Yeo AT, et al. Nat Immunol. 2022 Jun;23(6):971-984. doi: 10.1038/s41590-022-01215-0. Epub 2022 May 27. Nat Immunol. 2022. PMID: 35624211 Free PMC article.

4

Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma.

Yeo AT, Shah R, Aliazis K, Pal R, Xu T, Zhang P, Rawal S, Rose CM, Varn FS, Appleman VA, Yoon J, Varma H, Gygi SP, Verhaak RGW, Boussiotis VA, Charest A. Yeo AT, et al. Cancer Immunol Res. 2023 May 3;11(5):629-645. doi: 10.1158/2326-6066.CIR-22-0655. Cancer Immunol Res. 2023. PMID: 36881002 Free PMC article.

5

A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine.

Jun HJ, Appleman VA, Wu HJ, Rose CM, Pineda JJ, Yeo AT, Delcuze B, Lee C, Gyuris A, Zhu H, Woolfenden S, Bronisz A, Nakano I, Chiocca EA, Bronson RT, Ligon KL, Sarkaria JN, Gygi SP, Michor F, Mitchison TJ, Charest A. Jun HJ, et al. Among authors: yeo at. Nat Commun. 2018 Aug 6;9(1):3116. doi: 10.1038/s41467-018-05036-4. Nat Commun. 2018. PMID: 30082792 Free PMC article.

6

Pleiotropic tumor suppressive functions of PTEN missense mutations during gliomagenesis.

Jun HJ, Paulo JA, Appleman VA, Yaron-Barir TM, Johnson JL, Yeo AT, Rogers VA, Kuang S, Varma H, Gygi SP, Trotman LC, Charest A. Jun HJ, et al. Among authors: yeo at. iScience. 2024 Oct 28;27(12):111278. doi: 10.1016/j.isci.2024.111278. eCollection 2024 Dec 20. iScience. 2024. PMID: 39660053 Free PMC article.

7

A high-grade glioma with SOS1 amplification.

Vidal B, Bryke C, Hsu N, Alterman R, Yeo AT, Charest A, Varma H. Vidal B, et al. Among authors: yeo at. Clin Neuropathol. 2020 May/Jun;39(3):126-134. doi: 10.5414/NP301182. Clin Neuropathol. 2020. PMID: 31841105

8

EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.

Yeo AT, Jun HJ, Appleman VA, Zhang P, Varma H, Sarkaria JN, Charest A. Yeo AT, et al. Oncogene. 2021 Apr;40(15):2682-2696. doi: 10.1038/s41388-021-01721-9. Epub 2021 Mar 11. Oncogene. 2021. PMID: 33707748 Free PMC article.

9

Disulfide-mediated stabilization of the IκB kinase binding domain of NF-κB essential modulator (NEMO).

Zhou L, Yeo AT, Ballarano C, Weber U, Allen KN, Gilmore TD, Whitty A. Zhou L, et al. Among authors: yeo at. Biochemistry. 2014 Dec 23;53(50):7929-44. doi: 10.1021/bi500920n. Epub 2014 Dec 8. Biochemistry. 2014. PMID: 25400026 Free PMC article.

10

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Katayama R, Shaw AT, Khan TM, Mino-Kenudson M, Solomon BJ, Halmos B, Jessop NA, Wain JC, Yeo AT, Benes C, Drew L, Saeh JC, Crosby K, Sequist LV, Iafrate AJ, Engelman JA. Katayama R, et al. Among authors: yeo at. Sci Transl Med. 2012 Feb 8;4(120):120ra17. doi: 10.1126/scitranslmed.3003316. Epub 2012 Jan 25. Sci Transl Med. 2012. PMID: 22277784 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters